临床试验现场绩效指标仪器的开发:一个研究协议
Mattia Bozzetti1, Rosario Caruso2,3, Silvia Soncini4
1Department of Biomedicine and Prevention, University of Rome, Tor Vergata, Italy.
MethodsX
|February 3, 2025
概括
这项研究引入了一种新的临床试验场地性能测量 (CT-SPM) 以标准化多中心临床试验场地评估. 经过验证的工具将提高研究的效率和质量,降低成本.
科学领域:
- 临床研究方法论临床研究方法论
- 医疗服务研究 医疗服务研究
- 生物统计学 生物统计学
背景情况:
- 临床试验对于医学进步至关重要,但在效率和成本方面面临挑战.
- 在多中心研究中对现场性能进行不一致的评估,妨碍了有效的试验管理.
研究的目的:
- 开发和验证临床试验现场性能测量 (CT-SPM) 以评估临床试验中的"良好表现".
- 为了广泛应用,创建CT-SPM的综合版本和简体版本.
- 建立一个标准化的方法来评估临床试验现场的性能.
主要方法:
- 第一个阶段:通过专家共识选择指标.
- 第二阶段:对CT-SPM的可靠性和有效性的心理测试.
- 第三阶段:统计建模以定义"良好表现"的切线.
主要成果:
- 开发一个验证的临床试验现场性能测量 (CT-SPM).
- 创建一个全面的尺度和一个简短的版本,用于各种应用.
- 建立在临床试验场所的"良好表现"的统计界限.
结论:
- CT-SPM提供了一种标准化的方法来评估临床试验现场的性能.
- 这一措施可以提高多中心临床试验的质量和效率.
- 标准化绩效评估有可能降低研究成本并改善试验结果.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Study Designs in Epidemiology
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.


